A 58-year-old man on atorvastatin monotherapy has LDL-C of 95 mg/dL but remains at high cardiovascular risk. His physician adds ezetimibe. Which mechanism best distinguishes ezetimibe's action from that of statins in lowering cholesterol?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.